Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 6Completed 3Not yet recruiting 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2CNS 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1

Conditions

Oligodendroglioma 1Neoplastic Cells, Circulating 1Neoplasm Recurrence, Local 1Meningioma 1Lymphoma, Follicular 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Temozolomide 21Magnetic Resonance Spectroscopy 9Radiotherapy 8Blood Specimen Collection 8Cyclophosphamide 6Bevacizumab 6AZD 6244 6pembrolizumab 5Specimen Handling 4Radiation 4fludarabine 3dinutuximab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3vorasidenib 2tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2cemiplimab 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2Radiosurgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Spinal Puncture × CNS × Clear all
NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Mayo Clinic

Phase 1/2 Not yet recruiting
33 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

NCT07398170 2026-02-09

BIOLIMEN-1

University Hospital, Montpellier

Phase NA Not yet recruiting
15 enrolled
CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡